multi-omics analysis
Showing 1 - 25 of >10,000
Gynecological Rare Pathological Tumors
Not yet recruiting
- Rare Gynecological Tumors
- Multi-omics Analysis
- (no location specified)
Aug 3, 2023
Gastric Cancer, Multi-omics, Diagnosis Trial in Hangzhou (Without any intervention)
Active, not recruiting
- Gastric Cancer
- +2 more
- Without any intervention
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Nov 15, 2023
Diabetes, Type 2, PreDiabetes Trial in Stanford (Dietary intervention)
Not yet recruiting
- Diabetes Mellitus, Type 2
- PreDiabetes
- Dietary intervention
-
Stanford, CaliforniaStanford University
Aug 23, 2023
Acute Myeloid Leukemia Trial in Taipei
Enrolling by invitation
- Acute Myeloid Leukemia
-
Taipei, TaiwanNational Taiwan University Hospital
Aug 9, 2023
Primary Sclerosing Cholangitis, IBD Trial in Stanford (Rosuvastatin)
Recruiting
- Primary Sclerosing Cholangitis
- Inflammatory Bowel Diseases
-
Stanford, CaliforniaStanford University
Jun 12, 2023
Schizophrenia, Treatment-resistant Schizophrenia, Side Effect Trial (Aripiprazole, Paliperidone)
Not yet recruiting
- Schizophrenia
- +6 more
- (no location specified)
Sep 27, 2023
Nervous System Diseases, Cardiovascular and Cerebrovascular Diseases Trial in Jinan
Recruiting
- Nervous System Diseases
- Cardiovascular and Cerebrovascular Diseases
-
Jinan, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Oct 19, 2023
Phlegm-heat Syndrome in Ischemic Stroke Based on Multi-omics
Not yet recruiting
- Ischemic Stroke, Acute
- (no location specified)
Nov 19, 2022
Lung Tumor Malignant Trial in Milano (SBRT, Surgery)
Not yet recruiting
- Lung Neoplasm Malignant
- SBRT
- Surgery
-
Milano, MI, ItalyIstituto Europeo di Oncologia IRCCS
Jul 26, 2023
Lung Cancer Multi-omics Digital Human Avatars for Integrating
Not yet recruiting
- Non Small Cell Lung Cancer
- surgical resection
- (no location specified)
Apr 4, 2023
Minimal Residual Disease Using Multi-omics Approach
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
-
Shanghai, ChinaDepartment of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Nov 29, 2023
Drug Intervention Study of Spondyloarthritis
Enrolling by invitation
- Spondylarthritis
- questionnaire survey
-
Wenzhou, Zhejiang, ChinaXiaobing Wang
Aug 11, 2022
Host-microbiome Interaction in Chronic Obstructive Pulmonary
Not yet recruiting
- COPD Exacerbation
- Bronchiectasis With Acute Exacerbation
- No intervention
-
Shanghai, Shanghai, ChinaRuijin Hospital, Medical School of Shanghai Jiaotong University
Feb 20, 2023
Crohn Disease, Ulcerative Colitis Trial in Guangzhou (Biologics)
Recruiting
- Crohn Disease
- Ulcerative Colitis
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital, Sun Yat-sen University
Sep 14, 2022
Tongue Coating in Malignant Tumors of Digestive Tract
Recruiting
- Malignant Tumors of Digestive Tract
- Tongue coating sample collection and multi-omics analysis
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Mar 31, 2023
Multi-omics Analysis of Chronic Kidney Disease
Recruiting
- Potential Mechanisms Underlying the Microbiota-Gut-Kidney Axis in CKD
- renal function
-
Shanghai, Shanghai, ChinaDepartment of Nephrolgoy, Shanghai 10th People's Hospital
Sep 13, 2022
Genetic Predisposition Trial in Tübingen (Multi-OMICS)
Recruiting
- Genetic Predisposition
- Multi-OMICS
-
Tübingen, GermanyUniversity Hospital Tübingen
May 17, 2022
Systemic Lupus Erythematosus Trial in Nanjing
Not yet recruiting
- Systemic Lupus Erythematosus
-
Nanjing, ChinaNanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing
Sep 9, 2022
Multi-omics Analyses Reveal Microbiota-gut-brain Axis in ICU
Recruiting
- Postoperative Delirium
- +2 more
-
Beijing, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Chi
Nov 24, 2022
Recurrent and Metastatic CRC After Surgery by Multi-omics
Not yet recruiting
- Colorectal Cancer Metastatic
- no intervention
- (no location specified)
Aug 11, 2022
Polycystic Ovary Syndrome Trial in Shanghai (no intervention)
Recruiting
- Polycystic Ovary Syndrome
- no intervention
-
Shanghai, Shanghai, ChinaDepartment of Endocrinology, Shanghai Tenth People's Hospital
Jul 19, 2022
System of Cardiovascular and Cerebrovascular Diseases Based on
Not yet recruiting
- Coronary Artery Disease
- +11 more
- Observational; No Interventions were given.
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiantong University
Aug 14, 2023
Integrative Multi-Omics Testing for Immunotherapy Response in
Recruiting
- Lung Cancer
-
Guangzhou, Guangdong, ChinaNanfang hospital
Jun 29, 2023